La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

VIA Labs Bilan de santé

Santé financière contrôle des critères 5/6

VIA Labs possède un total de capitaux propres de NT$2.9B et une dette totale de NT$208.0M, ce qui porte son ratio d'endettement à 7.1%. Son actif total et son passif total sont NT$3.8B et de NT$926.3M. L'EBIT de VIA Labs est NT$100.3M ce qui fait que son ratio de couverture des intérêts -2.8. Elle dispose de liquidités et de placements à court terme de NT$1.7B.

Informations clés

7.1%

Ratio d'endettement

NT$208.00m

Dette

Ratio de couverture des intérêts	-2.8x
Argent liquide	NT$1.68b
Fonds propres	NT$2.91b
Total du passif	NT$926.32m
Total des actifs	NT$3.84b

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

VIA Labs, Inc. (TWSE:6756) May Have Run Too Fast Too Soon With Recent 29% Price Plummet

Aug 06

VIA Labs' (TWSE:6756) Shareholders Will Receive A Smaller Dividend Than Last Year

Apr 15

We Think You Can Look Beyond VIA Labs' (TWSE:6756) Lackluster Earnings

Mar 21

VIA Labs' (TWSE:6756) Shareholders Will Receive A Smaller Dividend Than Last Year

Mar 11

Is Weakness In VIA Labs, Inc. (TPE:6756) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Feb 03

Should VIA Labs, Inc. (TPE:6756) Be Part Of Your Dividend Portfolio?

Jan 12

We Like VIA Labs' (GTSM:6756) Returns And Here's How They're Trending

Dec 17

Getting In Cheap On VIA Labs, Inc. (GTSM:6756) Might Be Difficult

Nov 25

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de 6756 ( NT$2.0B ) dépassent ses passifs à court terme ( NT$902.5M ).

Passif à long terme: Les actifs à court terme de 6756 ( NT$2.0B ) dépassent ses passifs à long terme ( NT$23.8M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: 6756 dispose de plus de liquidités que de sa dette totale.

Réduire la dette: Le ratio d'endettement de 6756 est passé de 0% à 7.1% au cours des 5 dernières années.

Couverture de la dette: La dette de 6756 est bien couverte par le flux de trésorerie opérationnel ( 403% ).

Couverture des intérêts: 6756 gagne plus d'intérêts qu'il n'en paie, donc la couverture des paiements d'intérêts n'est pas un problème.

VIA Labs Bilan de santé

Santé financière contrôle des critères 5/6

Informations clés

Mises à jour récentes de la santé financière

Recent updates

Second quarter 2024 earnings released: EPS: NT$0.75 (vs NT$1.15 in 2Q 2023)

VIA Labs, Inc. (TWSE:6756) May Have Run Too Fast Too Soon With Recent 29% Price Plummet

Investor sentiment deteriorates as stock falls 19%

VIA Labs, Inc. to Report Q2, 2024 Results on Aug 08, 2024

First quarter 2024 earnings released: EPS: NT$0.73 (vs NT$0.22 in 1Q 2023)

VIA Labs' (TWSE:6756) Shareholders Will Receive A Smaller Dividend Than Last Year

Upcoming dividend of NT$2.00 per share

We Think You Can Look Beyond VIA Labs' (TWSE:6756) Lackluster Earnings

Full year 2023 earnings released: EPS: NT$2.62 (vs NT$10.57 in FY 2022)

VIA Labs' (TWSE:6756) Shareholders Will Receive A Smaller Dividend Than Last Year

Dividend of NT$2.00 announced

Investor sentiment deteriorates as stock falls 16%

VIA Labs, Inc., Annual General Meeting, Jun 20, 2024

New major risk - Revenue size

New minor risk - Share price stability

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: NT$1.15 (vs NT$3.73 in 2Q 2022)

Upcoming dividend of NT$7.49 per share at 3.2% yield

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 17%

Third quarter 2022 earnings released: EPS: NT$2.01 (vs NT$3.56 in 3Q 2021)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: NT$4.23 (vs NT$2.74 in 1Q 2021)

Price target increased to NT$510

Investor sentiment deteriorated over the past week

Upcoming dividend of NT$10.99 per share

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS NT$3.56 (vs NT$1.30 in 3Q 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: EPS NT$3.08 (vs NT$1.37 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

First quarter 2021 earnings released: EPS NT$2.74 (vs NT$1.31 in 1Q 2020)

Upcoming dividend of NT$4.50 per share

Robust Earnings May Not Tell The Whole Story For VIA Labs (TPE:6756)

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS NT$5.29 (vs NT$4.05 in FY 2019)

VIA Labs (TPE:6756) Is Achieving High Returns On Its Capital

Should VIA Labs (TPE:6756) Be Disappointed With Their 84% Profit?

Is Weakness In VIA Labs, Inc. (TPE:6756) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Should VIA Labs, Inc. (TPE:6756) Be Part Of Your Dividend Portfolio?

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

We Like VIA Labs' (GTSM:6756) Returns And Here's How They're Trending

New 90-day low: NT$298

Getting In Cheap On VIA Labs, Inc. (GTSM:6756) Might Be Difficult

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines